Literature DB >> 22009418

Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.

Dae-Weung Kim1, Chang Guhn Kim.   

Abstract

PURPOSE: We performed dual-time-point positron emission tomography imaging (DTPI) in patients without evidence of mediastinal lymph node metastasis to investigate the characteristics of fluorodeoxyglucose (FDG) uptake in benign mediastinal lymph nodes.
MATERIALS AND METHODS: A total of 118 mediastinal lesions in 24 patients were included in the study. The size, attenuation, maximum standardized uptake value (SUV), and retention indices (RI) were recorded on early and delayed positron emission tomography images for lymph node characterization.
RESULTS: The mean SUVs on the early and delayed scans of 118 lymph nodes were 3.3 ± 1.2 and 4.2 ± 1.7, respectively. The mean RI was 26.4% ± 24.5%. Higher FDG uptake was observed in patients with calcified nodules and bilateral FDG uptake and in lymph nodes with calcification or a short-axis diameter >10 mm.
CONCLUSION: In a tuberculosis-endemic area, increments of SUV or RI were frequently observed in benign mediastinal lymph nodes. Therefore, these values, based on mediastinal FDG uptake, might not be accurate indicators of malignant disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009418     DOI: 10.1007/s11604-011-0613-7

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  15 in total

1.  CT depiction of regional nodal stations for lung cancer staging.

Authors:  J P Ko; E A Drucker; J A Shepard; C F Mountain; C Dresler; B Sabloff; T C McLoud
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

2.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

3.  Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping.

Authors:  G M Glazer; B H Gross; L E Quint; I R Francis; F L Bookstein; M B Orringer
Journal:  AJR Am J Roentgenol       Date:  1985-02       Impact factor: 3.959

Review 4.  PET imaging in oncology.

Authors:  R Bar-Shalom; A Y Valdivia; M D Blaufox
Journal:  Semin Nucl Med       Date:  2000-07       Impact factor: 4.446

5.  Radiological manifestations of pulmonary tuberculosis.

Authors:  J Andreu; J Cáceres; E Pallisa; M Martinez-Rodriguez
Journal:  Eur J Radiol       Date:  2004-08       Impact factor: 3.528

6.  18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

Authors:  Ruoh-Fang Yen; Ke-Cheng Chen; Jang-Ming Lee; Yeun-Chung Chang; Jane Wang; Mei-Fang Cheng; Yen-Wen Wu; Yung-Chie Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-19       Impact factor: 9.236

7.  Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.

Authors:  Maroun Karam; Shayna Roberts-Klein; Narendra Shet; Johanna Chang; Paul Feustel
Journal:  J Nucl Med       Date:  2008-09       Impact factor: 10.057

8.  Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Authors:  Daisuke Uesaka; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Masato Sasaki; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

9.  Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.

Authors:  Won Jun Kang; June-Key Chung; Young So; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

10.  The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.

Authors:  X-L Lan; Y-X Zhang; Z-J Wu; Q Jia; H Wei; Z-R Gao
Journal:  Clin Radiol       Date:  2008-03-19       Impact factor: 2.350

View more
  2 in total

1.  Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer?

Authors:  Dae-Weung Kim; Woo Hyoung Kim; Chang Guhn Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-06-05

Review 2.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.